The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes

References

• PATH. Global HPV vaccine introduction overview; 2020. [accessed 2020 Nov 14]. https://path.azureedge.net/media/documents/Global_HPV_Vaccine_Intro_Overview_Slides_webversion_2020May.pdf.
   Google Scholar
• Arbyn M, Xu L. Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials. Expert Rev Vaccines. 2018;17(12):1085–91. doi:10.1080/14760584.2018.1548282.
   PubMed Web of Science ®Google Scholar
• Drolet M, Bénard É, Pérez N, Brisson M, Ali H, Boily M-C, Baldo V, Brassard P, Brotherton JML, Callander D, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497–509. doi:10.1016/S0140-6736(19)30298-3.
   PubMed Web of Science ®Google Scholar
• Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383(14):1340–48. doi:10.1056/NEJMoa1917338.
   PubMed Web of Science ®Google Scholar
• Kyrgiou M, Athanasiou A, Kalliala IEJ, Paraskevaidi M, Mitra A, Martin-Hirsch PPL, Arbyn M, Bennett P, Paraskevaidis E. Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease (Review). Cochrane Database Syst Rev. 2017;2017(11):CD012847.
   Google Scholar
• Niyibizi J, Zanré N, Mayrand M-H, Trottier H. Association between maternal human papillomavirus infection and adverse pregnancy outcomes: systematic review and meta-analysis. J Infect Dis. 2020;221(12):1925–37. doi:10.1093/infdis/jiaa054.
   PubMed Web of Science ®Google Scholar
• Yuill S, Egger S, Smith M, Velentzis L, Wrede CD, Bateson D, Canfell K. Has Human Papillomavirus (HPV) vaccination prevented adverse pregnancy outcomes? Population-level analysis after 8 years of a national HPV vaccination program in Australia. J Infect Dis. 2020;222(3):499–508. doi:10.1093/infdis/jiaa106.
   PubMed Web of Science ®Google Scholar
• World Health Organisation (WHO). WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand. 1977;56(3):247–53.
   PubMed Web of Science ®Google Scholar
• Chawanpaiboon S, Vogel JP, Moller A-B, Lumbiganon P, Petzold M, Hogan D, Landoulsi S, Jampathong N, Kongwattanakul K, Laopaiboon M, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019;7(1):e37–e46. doi:10.1016/S2214-109X(18)30451-0.
   PubMed Web of Science ®Google Scholar
• Chang HH, Larson J, Blencowe H, Spong CY, Howson CP, Cairns-Smith S, Lackritz EM, Lee SK, Mason E, Serazin AC, et al. Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet. 2013;381(9862):223–34. doi:10.1016/S0140-6736(12)61856-X.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare (AIHW). Data tables: australia’s mothers and babies 2018—in brief supplementary tables; 2020. [accessed 2020 June 1]. https://www.aihw.gov.au/reports/mothers-babies/australias-mothers-and-babies-2018-in-brief/data.
   Google Scholar
• Australian Institute of Health and Welfare (AIHW). Australia’s mothers and babies 2018: in brief. Perinatal statistics series no. 36. Cat. no. PER 108. Canberra, Australia: AIHW; 2020.
   Google Scholar
• World Health Organisation. March of dimes, the partnership for maternal NCH, Children St. born too soon: the global action report on preterm birth. Eds CP Howson, MV Kinney (JE Lawn). Geneva: World Health Organisation; 2012.
   Google Scholar
• World Health Organisation (WHO). Estimates for child causes of death 2000-2017; 2018. [accessed 2020 Oct 29]. https://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html.
   Google Scholar
• Lawn J, Gravett M, Nunes T, Rubens C, Stanton C. Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth. 2010;10(S1):S1–undefined. doi:10.1186/1471-2393-10-S1-S1.
   PubMed Web of Science ®Google Scholar
• Katz J, Lee ACC, Kozuki N, Lawn JE, Cousens S, Blencowe H, Ezzati M, Bhutta ZA, Marchant T, Willey BA, et al. Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet. 2013;382(9890):417–25. doi:10.1016/S0140-6736(13)60993-9.
   PubMed Web of Science ®Google Scholar
• Morisaki N, Togoobaatar G, Vogel JP, Souza JP, Rowland Hogue CJ, Jayaratne K, Ota E, Mori R. Risk factors for spontaneous and provider-initiated preterm delivery in high and low human development index countries: a secondary analysis of the World Health Organization multicountry survey on maternal and newborn health. BJOG. 2014;121(Suppl 1):101–09. doi:10.1111/1471-0528.12631.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84. doi:10.1016/S0140-6736(08)60074-4.
   PubMed Web of Science ®Google Scholar
• Ferrero DM, Larson J, Jacobsson B, Di Renzo GC, Norman JE, Martin JN, D’Alton M, Castelazo E, Howson CP, Sengpiel V, et al. Cross-country individual participant analysis of 4.1 million singleton births in 5 Countries with very high human development index confirms known associations but provides no biologic explanation for 2/3 of all preterm births. PLoS One. 2016;11(9):e0162506. doi:10.1371/journal.pone.0162506.
   PubMed Web of Science ®Google Scholar
• Menon R. Spontaneous preterm birth, a clinical dilemma: etiologic, pathophysiologic and genetic heterogeneities and racial disparity. Acta Obstet Gynecol Scand. 2008;87(6):590–600. doi:10.1080/00016340802005126.
   PubMed Web of Science ®Google Scholar
• Blondel B, Macfarlane A, Gissler M, Breart G, Zeitlin J. General obstetrics: preterm birth and multiple pregnancy in European countries participating in the PERISTAT project. BJOG. 2006;113(5):528–35. doi:10.1111/j.1471-0528.2006.00923.x.
   PubMed Web of Science ®Google Scholar
• Mercer BM, Goldenberg RL, Moawad AH, Meis PJ, Iams JD, Das AF, Caritis SN, Miodovnik M, Menard MK, Thurnau GR, et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. Conference abstract. Am J Obstet Gynecol. 1999;181(5I):1216–21. doi:10.1016/S0002-9378(99)70111-0.
   PubMed Web of Science ®Google Scholar
• McManemy J, Cooke E, Amon E, Leet T. Recurrence risk for preterm delivery. Am J Obstet Gynecol. 2007;196(6):576.e571–576. discussion 576.e576-577. doi:10.1016/j.ajog.2007.01.039.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Rosas-Bermúdez A, Kafury-Goeta AC. Birth spacing and risk of adverse perinatal outcomes: a meta-analysis. JAMA. 2006;295(15):1809–23. doi:10.1001/jama.295.15.1809.
   PubMed Web of Science ®Google Scholar
• Ball SJ, Pereira G, Jacoby P, de Klerk N, Stanley FJ. Re-evaluation of link between interpregnancy interval and adverse birth outcomes: retrospective cohort study matching two intervals per mother. BMJ. 2014;349:g4333. doi:10.1136/bmj.g4333.
   PubMed Web of Science ®Google Scholar
• Lemmers M, Verschoor MA, Hooker AB, et al. Dilatation and curettage increases the risk of subsequent preterm birth: a systematic review and meta-analysis. Hum Reprod. 2016;31(1):34–45.
   PubMed Web of Science ®Google Scholar
• Saccone G, Perriera L, Berghella V. Prior uterine evacuation of pregnancy as independent risk factor for preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;214(5):572–591.
   Google Scholar
• Ncube CN, Enquobahrie DA, Albert SM, Herrick AL, Burke JG. Association of neighborhood context with offspring risk of preterm birth and low birthweight: A systematic review and meta-analysis of population-based studies. Soc Sci Med. 2016;153:156–164.
   Google Scholar
• Beyerlein A, Lack N, Maier W. Associations of area-level deprivation with adverse obstetric and perinatal outcomes in Bavaria, Germany: Results from a cross-sectional study. PLoS One. 2020;15(7):e0236020.
   Google Scholar
• Liu B, Xu G, Sun Y, et al. Maternal cigarette smoking before and during pregnancy and the risk of preterm birth: A dose-response analysis of 25 million mother-infant pairs. PLoS Med. 2020;17(8):e1003158.
   PubMed Web of Science ®Google Scholar
• Patra J, Bakker R, Irving H, Jaddoe V, Malini S, Rehm J. Dose–response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)—a systematic review and meta‐analyses. BJOG. 2011;118:1411–1421.
   PubMed Web of Science ®Google Scholar
• Khatibi AMDP, Brantsaeter A-LMP, Sengpiel VMDP, et al. Prepregnancy maternal body mass index and preterm delivery. Am J Obstet Gynecol. 2012;207(3):212.e211-212.
   Google Scholar
• Bird AL, Grant CC, Bandara DK, Mohal J, Atatoa-Carr P, Wise MR, Inskip H, Miyahara M, Morton SMB. Maternal health in pregnancy and associations with adverse birth outcomes: evidence from growing up in New Zealand. Aust N Z J Obstet Gynaecol. 2017;57(1):16–24. doi:10.1111/ajo.12557.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare (AIHW). Diabetes in pregnancy 2014–2015. Bulletin no. 146. Cat. no. CDK 7. Canberra, Australia: AIHW. 2019.
   Google Scholar
• Sheehan PM, Nankervis A, Araujo Júnior E, Da Silva Costa F. Maternal Thyroid Disease and Preterm Birth: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2015;100(11):4325–4331.
   Google Scholar
• Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007;21(3):375–390.
   PubMed Web of Science ®Google Scholar
• Thorsen P, Vogel I, Olsen J, et al. Bacterial vaginosis in early pregnancy is associated with low birth weight and small for gestational age, but not with spontaneous preterm birth: A population-based study on Danish women. J Matern Fetal Neonatal Med. 2006;19(1):1–7.
   PubMed Web of Science ®Google Scholar
• Tang W, Mao J, Li KT, et al. Pregnancy and fertility-related adverse outcomes associated with Chlamydia trachomatis infection: a global systematic review and meta-analysis. Sex Transm Infect. 2020;96(5):322–329.
   PubMed Web of Science ®Google Scholar
• Owens DK, Davidson KW, Krist AH, et al. Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(12):1188–1194.
   PubMed Web of Science ®Google Scholar
• Iheozor‐Ejiofor Z, Middleton P, Esposito M, Glenny AM. Treating periodontal disease for preventing adverse birth outcomes in pregnant women. Cochrane Database Syst Rev. 2017(6).
   Google Scholar
• The American College of Obstetricians and Gynecologists. Practice Bulletin No. 130: Prediction and Prevention of Preterm Birth. Obstet Gynecol.2012;120(4):964-973.
   Google Scholar
• Owens DK, Davidson KW, Krist AH, et al. Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement. JAMA. 2020;323(13):1286–1292.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare (AIHW). Stillbirths and neonatal deaths in Australia 2017. Cat. no. PER 107. Canberra, Australia: AIHW.2020.
   Google Scholar
• Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ. 2013;346:f108. doi:10.1136/bmj.f108.
   PubMed Web of Science ®Google Scholar
• Lee ACC, Kozuki N, Cousens S, Stevens GA, Blencowe H, Silveira MF, Sania A, Rosen HE, Schmiegelow C, Adair LS, et al. On behalf of: for the CHERG small-for-gestational-age-preterm birth working group. Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets. BMJ. 2017;358:j3677. doi:10.1136/bmj.j3677.
   PubMed Web of Science ®Google Scholar
• Crispi F, Miranda J, Gratacós E. Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and opportunities for prevention of adult disease. Am J Obstet Gynecol. 2018;218(2):S869–S879. doi:10.1016/j.ajog.2017.12.012.
   PubMed Web of Science ®Google Scholar
• Ewing AC, Ellington SR, Shapiro-Mendoza CK, Barfield WD, Kourtis AP. Full-term small-for-gestational-age newborns in the U.S.: characteristics, trends, and morbidity. Matern Child Health J. 2017;21(4):786–96. doi:10.1007/s10995-016-2165-z.
   PubMed Web of Science ®Google Scholar
• Morisaki SN, Esplin WM, Varner WM, Henry WE, Oken WE. Declines in birth weight and fetal growth independent of gestational length. Obstet Gynecol. 2013;121(1):51–58. doi:10.1097/AOG.0b013e318278d014.
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynaecologists. The investigation and management of the small-for-gestational age fetus, 2nd ed. 2013 Minor revisions 2014. Green-top Guideline No 31. London, United Kingdom: RCOG. 2013.
   Google Scholar
• Gestation Network. Perintal institute. Growth charts. [accessed 2020 Sept 14]. https://www.gestation.net/growthcharts.htm.
   Google Scholar
• Mongelli M, Figueras F, Francis A, Gardosi J. A customized birthweight centile calculator developed for an Australian population. Aust N Z J Obstet Gynaecol. 2007;47(2):128–31. doi:10.1111/j.1479-828X.2007.00698.x.
   PubMed Web of Science ®Google Scholar
• McCowan L, Stewart AW, Francis A, Gardosi J. A customised birthweight centile calculator developed for a New Zealand population. Aust N Z J Obstet Gynaecol. 2004;44(5):428–31. doi:10.1111/j.1479-828X.2004.00272.x.
   PubMed Web of Science ®Google Scholar
• Francis A, Hugh O, Gardosi J. Customized vs INTERGROWTH-21(st) standards for the assessment of birthweight and stillbirth risk at term. Am J Obstet Gynecol. 2018;218(2s):S692–s699. doi:10.1016/j.ajog.2017.12.013.
   PubMed Web of Science ®Google Scholar
• Gardosi J, Clausson B, Francis A. The value of customised centiles in assessing perinatal mortality risk associated with parity and maternal size. BJOG. 2009;116(10):1356–63. doi:10.1111/j.1471-0528.2009.02245.x.
   PubMed Web of Science ®Google Scholar
• Odibo AO, Francis A, Cahill AG, Macones GA, Crane JP, Gardosi J. Association between pregnancy complications and small-for-gestational-age birth weight defined by customized fetal growth standard versus a population-based standard. J Matern Fetal Neonatal Med. 2011;24(3):411–17. doi:10.3109/14767058.2010.506566.
   PubMed Web of Science ®Google Scholar
• McCowan LM, Harding JE, Stewart AW. Customized birthweight centiles predict SGA pregnancies with perinatal morbidity. BJOG. 2005;112(8):1026–33. doi:10.1111/j.1471-0528.2005.00656.x.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Peltier MR, Chavez MR, Kirby RS, Getahun D, Vintzileos AM. Recurrence of Ischemic Placental Disease. Obstet Gynecol. 2007;110(1):128–133.
   PubMed Web of Science ®Google Scholar
• Taylor LK, Lee YYC, Lim K, Simpson JM, Roberts CL, Morris J. Potential prevention of small for gestational age in Australia: A population-based linkage study. BMC Pregnancy Childbirth. 2013;13
   PubMed Web of Science ®Google Scholar
• Anderson NH, Sadler LC, Stewart AW, Fyfe EM, McCowan LM. Independent risk factors for infants who are small for gestational age by customised birthweight centiles in a multi-ethnic New Zealand population. Aust N Z J Obstet Gynaecol. 2013;53(2):136–142.
   Google Scholar
• Gardosi J, Francis A. Adverse pregnancy outcome and association with small for gestational age birthweight by customized and population-based percentiles. Am J Obstet Gynecol. 2009;201(1):28.e21-28. e28.
   Google Scholar
• Kozuki N, Lee AC, Silveira MF, et al. The associations of birth intervals with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health. 2013;13 Suppl 3\(Suppl 3):S3.
   Google Scholar
• Ruiz M, Goldblatt P, Morrison J, et al. Mother's education and the risk of preterm and small for gestational age birth: a DRIVERS meta-analysis of 12 European cohorts. J Epidemiol Community Health. 2015;69(9):826–833.
   PubMed Web of Science ®Google Scholar
• Clausson B, Cnattingius S, Axelsson O. Preterm and term births of small for gestational age infants: a population-based study of risk factors among nulliparous women. Br J Obstet Gynaecol. 1998;105(9):1011–1017.
   Google Scholar
• Bickerstaff M, Beckmann M, Gibbons K, Flenady V. Recent cessation of smoking and its effect on pregnancy outcomes: Recent cessation of smoking. Aust N Z J Obstet Gynaecol. 2012;52(1):54–58.
   PubMed Web of Science ®Google Scholar
• Cheney K FR, Barratt AL, McGeechan K, de Vries B, Ogle R, Black KI. Population attributable fractions of perinatal outcomes for nulliparous women associated with overweight and obesity, 1990–2014. Med J Aust. 2018;208(3):119–125.
   Google Scholar
• Hinkle S, Albert P, Mendola P, et al. Differences in risk factors for incident and recurrent small‐for‐gestational‐age birthweight: a hospital‐based cohort study. BJOG. 2014;121(9):1080–1089.
   PubMed Web of Science ®Google Scholar
• World Health Organisation (WHO). WHA global nutrition targets 2025: low birth weight policy brief; 2014. [accessed 2021 Feb 4]. https://www.who.int/nutrition/topics/globaltargets_lowbirthweight_policybrief.pdf.
   Google Scholar
• Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, Prendiville W, Paraskevaidis E. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ. 2008;337(7673):798–803. doi:10.1136/bmj.a1284.
   Google Scholar
• Arbyn M, Redman CWE, Verdoodt F, Kyrgiou M, Tzafetas M, Ghaem-Maghami S, Petry K-U, Leeson S, Bergeron C, Nieminen P, et al. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis. Lancet Oncol. 2017;18(12):1665–79. doi:10.1016/S1470-2045(17)30700-3.
   PubMed Web of Science ®Google Scholar
• Cancer Council Australia Cervical Cancer Screening Guidelines Working Party. National cervical screening program: guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding. https://wiki.cancer.org.au/australia/Guidelines:Cervical_cancer/Screening. [accessed 2021 Feb 9]. https://wiki.cancer.org.au/australiawiki/index.php?oldid=214377.
   Google Scholar
• Sasieni P, Castanon A, Landy R, Kyrgiou M, Kitchener H, Quigley M, Poon L, Shennan A, Hollingworth A, Soutter WP, et al. Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent symposium. BJOG. 2016;123(9):1426–29. doi:10.1111/1471-0528.13839.
   PubMed Web of Science ®Google Scholar
• Pinder LF, Parham GP, Basu P, Muwonge R, Lucas E, Nyambe N, Sauvaget C, Mwanahamuntu MH, Sankaranarayanan R, Prendiville W, et al. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 2020;21(1):175–84. doi:10.1016/S1470-2045(19)30635-7.
   PubMed Web of Science ®Google Scholar
• World Health Organisation (WHO). WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• Jakobsson M, Norwitz ER Reproductive effects of cervical excisional and ablative procedures. UpToDate; 2020. [accessed 2021 Feb 2]. https://www.wolterskluwer.com/en/solutions/uptodate.
   Google Scholar
• Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;345(6198):760–65. doi:10.1126/science.1251816.
   PubMed Web of Science ®Google Scholar
• Simoens C, Goffin F, Simon P, Barlow P, Antoine J, Foidart J-M, Arbyn M. Adverse obstetrical outcomes after treatment of precancerous cervical lesions: a Belgian multicentre study. BJOG. 2012;119(10):1247–55. doi:10.1111/j.1471-0528.2012.03429.x.
   PubMed Web of Science ®Google Scholar
• Bruinsma FJ, Quinn MA. The risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysis. (Report). BJOG. 2011;118(9):1031. doi:10.1111/j.1471-0528.2011.02944.x.
   PubMed Web of Science ®Google Scholar
• Castanon A, Brocklehurst P, Evans H, Peebles D, Singh N, Walker P, Patnick J, Sasieni P. Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study. BMJ. 2012;345. doi:10.1136/bmj.e5174.
   Google Scholar
• Aldhous M, Bhatia R, Pollock R, Vragkos D, Cuschieri K, Cubie HA, Norman JE, Stock SJ. HPV infection and pre-term birth: a data-linkage study using Scottish Health Data [version 1; peer review: 3 approved]. Wellcome Open Res. 2019;4:48. doi:10.12688/wellcomeopenres.15140.1.
   PubMedGoogle Scholar
• Kwon JY, Romero R, Mor G. New insights into the relationship between viral infection and pregnancy complications. Am J Reprod Immunol. 2014;71(5):387–90. doi:10.1111/aji.12243.
   PubMed Web of Science ®Google Scholar
• Gomez LM, Ma Y, Ho C, McGrath CM, Nelson DB, Parry S. Placental infection with human papillomavirus is associated with spontaneous preterm delivery. Hum Reprod. 2008;23(3):709–15. doi:10.1093/humrep/dem404.
   PubMed Web of Science ®Google Scholar
• Ghebreyesus TA WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer; 2018. [accessed 2019 July 10]. https://www.who.int/reproductivehealth/call-to-action-elimination-cervical-cancer/en/.
   Google Scholar
• Gallagher KE, LaMontagne DS, Watson-Jones D. Status of HPV vaccine introduction and barriers to country uptake. Vaccine. 2018;36(32):4761–67. doi:10.1016/j.vaccine.2018.02.003.
   PubMed Web of Science ®Google Scholar
• Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, De Sanjosé S, Castellsagué X. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016 e453-e463;4(7):e453–e463. doi:10.1016/S2214-109X(16)30099-7.
   PubMed Web of Science ®Google Scholar
• Bruni L, Saura-Lázaro A, Montoliu A, Brotons M, Alemany L, Diallo MS, Afsar OZ, LaMontagne DS, Mosina L, Contreras M, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019. Prev Med. 2020;144:106399–106399. doi:10.1016/j.ypmed.2020.106399.
   PubMed Web of Science ®Google Scholar
• Baussano I, Tshomo U, Tenet V, Heideman DAM, Wangden T, Franceschi S, Clifford GM. Prevalence of human papillomavirus and estimation of human papillomavirus vaccine effectiveness in Thimphu, Bhutan, in 2011-2012 and 2018: a cross-sectional study. Ann Intern Med. 2020;173(11):888–94. doi:10.7326/M20-2849.
   PubMed Web of Science ®Google Scholar
• Sayinzoga F, Umulisa MC, Sibomana H, Tenet V, Baussano I, Clifford GM. Human papillomavirus vaccine coverage in Rwanda: a population-level analysis by birth cohort. Vaccine. 2020;38(24):4001–05. doi:10.1016/j.vaccine.2020.04.021.
   PubMed Web of Science ®Google Scholar
• de Sanjose S, Quint WGV, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin H-R, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56. doi:10.1016/S1470-2045(10)70230-8.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Human papillomavirus. WHO position paper. Weekly Epidemiol Rec 2009;84:118–31.
   PubMedGoogle Scholar
• Food and Drug Administration. Gardasil 9; 2020. [accessed 2020 Nov 10]. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM426457.pdf.
   Google Scholar
• World Health Organization (WHO). Human papillomavirus vaccines : WHO position paper, October 2014. Weekly Epidemiol Rec 2014;89:465–91.
   PubMedGoogle Scholar
• Romanowski B, de Borba PC, Naud PS, Roteli-Martins CM, De Carvalho NS, Teixeira JC, Aoki F, Ramjattan B, Shier RM, Somani R, et al. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet. 2009;374(9706):1975–85.
   PubMed Web of Science ®Google Scholar
• Machalek DA, Garland SM, Brotherton JML, Bateson D, McNamee K, Stewart M, Rachel Skinner S, Liu B, Cornall AM, Kaldor JM, et al. Very low prevalence of vaccine human papillomavirus types among 18- to 35-year old Australian women 9 years following implementation of vaccination. J Infect Dis. 2018;217(10):1590–600. doi:10.1093/infdis/jiy075.
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Naleway AL, Lewis RM, Crane B, Querec TD, Weinmann S, Steinau M, Unger ER. Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: evidence of direct and herd effects of vaccination. Vaccine. 2019;37(29):3918–24. doi:10.1016/j.vaccine.2019.04.099.
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Naleway AL, Klein NP, Lewis RM, Crane B, Querec TD, Hsiao A, Aukes L, Timbol J, Weinmann S, et al. Human Papillomavirus vaccine effectiveness against HPV infection: evaluation of one, two, and three doses. J Infect Dis. 2020;221(6):910–18. doi:10.1093/infdis/jiz555.
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Drolet M, Perez N, Jit M, Brisson M. Human papillomavirus vaccine effectiveness by number of doses: systematic review of data from national immunization programs. Vaccine. 2018;36(32):4806–15. doi:10.1016/j.vaccine.2018.01.057.
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R, Joshi S, Muwonge R, Esmy PO, Basu P, Prabhu P, Bhatla N, Nene BM, Shaw J, Poli URR, et al. Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study. Vaccine. 2018;36(32):4783–91. doi:10.1016/j.vaccine.2018.02.087.
   PubMed Web of Science ®Google Scholar
• Smith MA, Liu B, McIntyre P, Menzies R, Dey A, Canfell K. Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data. J Infect Dis. 2015;211(1):91–99. doi:10.1093/infdis/jiu370.
   PubMed Web of Science ®Google Scholar
• Arbyn MXL, Simoens C, Martin-Hirsch PPL. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors (Review). Cochrane Database Syst Rev. 2018; (5). Art. No.: CD009069.doi: 10.1002/14651858.CD009069.pub3
   PubMed Web of Science ®Google Scholar
• Robertson G, Robson SJ. Excisional treatment of cervical dysplasia in Australia 2004-2013: a population-based study. J Oncol. 2016;2016:3056407. doi:10.1155/2016/3056407.
   PubMed Web of Science ®Google Scholar
• Brotherton JML, Budd A, Rompotis C, Bartlett N, Malloy MJ, Andersen RL, Coulter KA, Couvee PW, Steel N, Ward GH, et al. Is one dose of human papillomavirus vaccine as effective as three?: a national cohort analysis. Papillomavirus Res. 2019;8:100177. doi:10.1016/j.pvr.2019.100177.
   PubMed Web of Science ®Google Scholar
• Rodriguez AM, Zeybek B, Vaughn M, Westra J, Kaul S, Montealegre JR, Lin Y-L, Kuo Y-F. Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: a database study. Cancer. 2020;126(8):1656–67. doi:10.1002/cncr.32700.
   PubMed Web of Science ®Google Scholar
• Xu L, Selk A, Garland SM, Bogliatto F, Kyrgiou M, Weyers S, Arbyn M. Prophylactic vaccination against human papillomaviruses to prevent vulval and vaginal cancer and their precursors. Expert Rev Vaccines. 2019;18(11):1157–66. doi:10.1080/14760584.2019.1692658.
   PubMed Web of Science ®Google Scholar
• Derkay CS, Darrow DH. Recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 2006;115(1):1–11. doi:10.1177/000348940611500101.
   PubMed Web of Science ®Google Scholar
• Novakovic D, Cheng ATL, Zurynski Y, Booy R, Walker PJ, Berkowitz R, Harrison H, Black R, Perry C, Vijayasekaran S, et al. A prospective study of the incidence of Juvenile-Onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis. 2018;217(2):208–12. doi:10.1093/infdis/jix498.
   PubMed Web of Science ®Google Scholar
• Merck Sharp & Dohme Corp. GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]; 2011.
   Google Scholar
• Merck Sharp & Dohme Corp. GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant); 2020.
   Google Scholar
• Bukowinski AT, Hall C, Chang RN, Gumbs GR, Marie S, Conlin A. Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy. Vaccine. 2020;38(37):5933–39. doi:10.1016/j.vaccine.2020.06.073.
   PubMed Web of Science ®Google Scholar
• Wang A, Liu C, Wang Y, Yin A, Wu J, Zhang C, Luo M, Du L, Xiong Y, Zhao X, et al. Pregnancy outcomes after human papillomavirus vaccination in periconceptional period or during pregnancy: a systematic review and meta-analysis. Hum Vaccin Immunother. 2020;16(3):581–89. doi:10.1080/21645515.2019.1662363.
   PubMed Web of Science ®Google Scholar
• Canfell K. HPV vaccination and pregnancy. BMJ. 2015;351:h4705. doi:10.1136/bmj.h4705.
   PubMed Web of Science ®Google Scholar
• Wacholder S, Chen BE, Wilcox A, Macones G, Gonzalez P, Befano B, Hildesheim A, Rodriguez AC, Solomon D, Herrero R, et al. Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials. BMJ. 2010;340(mar02 1):c712. doi:10.1136/bmj.c712.
   PubMed Web of Science ®Google Scholar
• Kalliala I, Eriksson T, Aro K, Hokkanen M, Lehtinen M, Gissler M, Nieminen P. Preterm birth rate after bivalent HPV vaccination: registry-based follow-up of a randomized clinical trial. Prev Med. 2021;146:106473. doi:10.1016/j.ypmed.2021.106473.
   PubMed Web of Science ®Google Scholar
• Reitan T, Callinan S. Changes in smoking rates among pregnant women and the general female population in Australia, Finland, Norway, and Sweden. Nicotine Tob Res. 2017;19(3):282–89. doi:10.1093/ntr/ntw188.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare (AIHW). Australia’s mothers and babies 2015—in brief. Canberra, Australia: AIHW; 2017.
   Google Scholar
• Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546–56. doi:10.1016/j.vaccine.2012.03.063.
   PubMed Web of Science ®Google Scholar
• Fernández de Casadevante V, Gil Cuesta J, Cantarero-Arévalo L. Determinants in the uptake of the human Papillomavirus vaccine: a systematic review based on European studies. Front Oncol. 2015;5(141). doi:10.3389/fonc.2015.00141.
   PubMedGoogle Scholar
• Tabrizi SN, Brotherton JML, Kaldor JM, Skinner SR, Liu B, Bateson D, McNamee K, Garefalakis M, Phillips S, Cummins E, et al. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. J Infect Dis. 2014;14(10):958–66.
   Google Scholar
• Stoler HM. Human Papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol. 2000;19(1):16–28. doi:10.1097/00004347-200001000-00004.
   PubMed Web of Science ®Google Scholar
• Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, Miller S, Canjura-Clayton LK, Farhat S, Broering JM, et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet. 2004;364(9446):1678–83. doi:10.1016/S0140-6736(04)17354-6.
   PubMed Web of Science ®Google Scholar
• Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367(9509):489–98. doi:10.1016/S0140-6736(06)68181-6.
   PubMed Web of Science ®Google Scholar
• Crane JM. Pregnancy outcome after loop electrosurgical excision procedure: a systematic review. Obstet Gynecol. 2003;102(5 Pt 1):1058–62. doi:10.1016/s0029-7844(03)00741-5.
   PubMed Web of Science ®Google Scholar
• Wright TC Jr., Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 2007;197(4):340–45. doi:10.1016/j.ajog.2007.07.050.
   PubMed Web of Science ®Google Scholar
• Wright TC, Jr., Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D.2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197(4):346-355.
   Google Scholar
• National Health and Medical Research Council (NHMRC). Screening to prevent cervical cancer: guidelines for the management of asymptomatic women with screen detected abnormalities; 2005 [accessed 2020 November 18]. http://webarchive.nla.gov.au/gov/20170816100344/https://www.nhmrc.gov.au/guidelines-publications/wh39.
   Google Scholar
• Noehr KB, Jensen KA, Frederiksen KK, Tabor KA, Kjaer KS. Depth of cervical cone removed by loop electrosurgical excision procedure and subsequent risk of spontaneous preterm delivery. Obstet Gynecol. 2009;114(6):1232–38. doi:10.1097/AOG.0b013e3181bf1ef2.
   PubMed Web of Science ®Google Scholar
• The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Women’s health committee. Measurement of cervical length for prediction of preterm birth; 2006. Reviewed 2017. [accessed 2019 July 10]. https://www.ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27s%20Health/Statement%20and%20guidelines/Clinical-Obstetrics/Measurement-of-cervical-length-for-prediction-of-preterm-birth(C-Obs-27)-Review-July-2017.pdf?ext=.pdf.
   Google Scholar
• The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Women’s health committee. Progesterone: use in the second and third trimester of pregnancy for the prevention of preterm birth 2010. Reviewed; 2017. [accessed 2019 July 10]. https://www.ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27s%20Health/Statement%20and%20guidelines/Clinical-Obstetrics/Progesterone-use-in-the-second-and-third-trimester-(C-Obs-29b)-Review-July-2017.pdf?ext=.pdf.
   Google Scholar
• Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, Schiller JT, Gonzalez P, Dubin G, Porras C, et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298(7):743–53. doi:10.1001/jama.298.7.743.
   PubMed Web of Science ®Google Scholar
• Giddings S, Clifford S, Madurasinghe V, Gardosi J. PFM.69 Customised vs uncustomised ultrasound charts in the assessment of perinatal mortality risk in the south asian maternity population. Arch Dis Child Fetal Neonatal Ed. 2014;99(Suppl 1):A104.2–A104. Web. doi:10.1136/archdischild-2014-306576.298.
   Google Scholar
• Cheah SL, Scarf VL, Rossiter C, Thornton C, Homer CSE. Creating the first national linked dataset on perinatal and maternal outcomes in Australia: methods and challenges. J Biomed Inform. 2019;93:103152. doi:10.1016/j.jbi.2019.103152.
   PubMed Web of Science ®Google Scholar
• Velentzis LS, Caruana M, Simms KT, Lew J-B, Shi J-F, Saville M, Smith MA, Lord SJ, Tan J, Bateson D, et al. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. Int J Cancer. 2017;141(12):2410–22. doi:10.1002/ijc.30926.
   PubMed Web of Science ®Google Scholar
• Depuydt CE, Verstraete L, Berth M, Beert J, Bogers J-P, Salembier G, Vereecken AJ, Bosmans E. Human papillomavirus positivity in women undergoing intrauterine insemination has a negative effect on pregnancy rates. Gynecol Obstet Invest. 2016;81(1):41–46. doi:10.1159/000434749.
   PubMed Web of Science ®Google Scholar
• Souho T, Benlemlih M, Bennani B. Human papillomavirus infection and fertility alteration: a systematic review. PLoS One. 2015;10(5):e0126936. doi:10.1371/journal.pone.0126936.
   PubMed Web of Science ®Google Scholar